Business Context and Reporting Period
This Form 8-K Current Report was filed by Prestige Consumer Healthcare Inc. on May 8, 2024. The report discloses a corporate governance event: the election of a new member to the Board of Directors.
Key Financial Metrics
This filing does not contain financial performance data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The material change reported is the addition of John F. Kelly to the Board of Directors, effective May 7, 2024. Mr. Kelly has been appointed to the Compensation and Talent Management Committee and the Nominating and Corporate Governance Committee.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. No specific risks or contingencies are disclosed in this report. The document confirms there are no reportable related person transactions between the Company and Mr. Kelly.
Investor Verification Checklist
- Verify the official appointment of John F. Kelly to the Board of Directors and his committee assignments.
- Review Mr. Kelly's background, specifically his 40-year tenure at Pfizer Inc. and experience in quality operations and EHS.
- Confirm the absence of any undisclosed related party transactions as stated in the filing.
- Note that this filing does not impact current financial statements or provide updated earnings guidance.